Maintenance of HIV-specific CD4+ T cell help distinguishes HIV-2 from HIV-1 infection

Journal of Immunology

Volumn 176, Issue 11, 2006, Pages 6973-6981

  Duvall, Melody G ^a,c   Jaye, Assan ^b   Dong, Tao ^a   Brenchley, Jason M ^c   Alabi, Abraham S ^b   Jeffries, David J ^b   Van Der Sande, Marianne ^b   Togun, Toyin O ^b   McConkey, Samuel J ^b   Douek, Daniel C ^c   McMichael, Andrew J ^a   Whittle, Hilton C ^b   Koup, Richard A ^c   Rowland Jones, Sarah L ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; GAMMA INTERFERON; INTERLEUKIN 2;

ARTICLE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CYTOKINE PRODUCTION; DISEASE COURSE; FLOW CYTOMETRY; GAMBIA; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MEMORY T LYMPHOCYTE; PRIORITY JOURNAL; PROGNOSIS;

EID: 33646869319     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.176.11.6973     Document Type: Article

References (59)

1. + T cell responses associated with control of viremia. Science 278: 1447-1450.
2. Rosenberg, E. S., M. Altfeld, S. H. Poon, M. N. Phillips, B. M. Wilkes, R. L. Eldridge, G. K. Robbins, R. T. D'Aquila, P. J. Goulder, and B. D. Walker. 2000. Immune control of HIV-1 after early treatment of acute infection. Nature 407: 523-526.
3. + cell numbers and clinical staging. J. Clin. Invest. 84: 1892-1899.
4. Poulsen, A. G., P. Aaby, O. Larsen, H. Jensen, A. Naucler, I. M. Lisse, C. B. Christiansen, F. Dias, and M. Melbye. 1997. 9-Year HIV-2-associated mortality in an urban community in Bissau, West Africa. Lancet 349: 911-914.
5. Schim van der Loeff, M. F., S. Jaffar, A. A. Aveika, S. Sabally, T. Corrah, E. Harding, A. Alabi, A. Bayang, K. Ariyoshi, and H. C. Whittle. 2002. Mortality of HIV-1, HIV-2 and HIV-1/HIV-2 dually infected patients in a clinic-based cohort in The Gambia. AIDS 16: 1775-1783.
6. Ariyoshi, K., S. Jaffar, A. S. Alabi, N. Berry, M. Schim van der Loeff, S. Sabally, P. T. N'Gom, T. Corrah, R. Tedder, and H. Whittle. 2000. Plasma RNA viral load predicts the rate of CD4 T cell decline and death in HIV-2-infected patients in West Africa. AIDS 14: 339-344.
7. Arien, K. K., A. Abraha, M. E. Quinones-Mateu, L. Kestens, G. Vanham, and E. J. Arts. 2005. The replicative fitness of primary human immunodeficiency virus type 1 (HIV-1) group M, HIV-1 group O, and HIV-2 isolates. J. Virol. 79: 8979-8990.
8. Blaak, H., P. H. Boers, M. Schutten, M. E. Van Der Enden, and A. D. Osterhaus. 2004. HIV-2-infected individuals with undetectable plasma viremia carry replication-competent virus in peripheral blood lymphocytes. J. Acquir. Immune. Defic. Syndr. 36: 777-782.
9. McClure, M. O., Q. J. Sattentau, P. C. Beverley, J. P. Hearn, A. K. Fitzgerald, A. J. Zuckerman, and R. A. Weiss. 1987. HIV infection of primate lymphocytes and conservation of the CD4 receptor. Nature 330: 487-489.
10. Schramm, B., M. L. Penn, E. H. Palacios, R. M. Grant, F. Kirchhoff, and M. A. Goldsmith. 2000. Cytopathicity of human immunodeficiency virus type 2 (HIV-2) in human lymphoid tissue is coreceptor dependent and comparable to that of HIV-1. J. Virol. 74: 9594-9600.
11. Ariyoshi, K., N. Berry, A. Wilkins, D. Ricard, P. Aaby, A. Naucler, P. T. Ngom, O. Jobe, S. Jaffar, F. Dias, et al. 1996. A community-based study of human immunodeficiency virus type 2 provirus load in rural village in West Africa. J. Infect. Dis. 173: 245-248.
12. + lymphopenia in HIV type 2-infected individuals. AIDS Res. Hum. Ketroviruses 10: 1031-1037.
13. + lymphocyte count differs in monotypic and dual HIV infections. J. Hum. Virol. 2: 45-51.
14. Berry, N., S. Jaffar, M. Schim van der Loeff, K. Ariyoshi, E. Harding, P. T. N'Gom, F. Dias, A. Wilkins, D. Ricard, P. Aaby, et al. 2002. Low level viremia and high CD4% predict normal survival in a cohort of HIV type-2-infected villagers. AIDS Res. Hum. Retroviruses 18: 1167-1173.
15. Kanki, P. J., K. U. Travers, S. MBoup, C. C. Hsieh, R. G. Marlink, A. Gueye-NDiaye, T. Siby, I. Thior, M. Hernandez-Avila, J. L. Sankale, et al. 1994. Slower heterosexual spread of HIV-2 than HIV-1. Lancet 343: 943-946.
16. O'Donovan, D., K. Ariyoshi, P. Milligan, M. Ota, L. Yamuah, R. Sarge-Njie, and H. Whittle. 2000. Maternal plasma viral RNA levels determine marked differences in mother-to-child transmission rates of HIV-1 and HIV-2 in The Gambia: MRC/Gambia Government/University College London Medical School working group on mother-child transmission of HIV. AIDS 14: 441-448.
17. Whittle, H. C., K. Ariyoshi, and S. Rowland-Jones. 1998. HIV-2 and T cell recognition. Curr. Opin. Immunol. 10: 382-387.
18. Gotch, F., S. N. McAdam, C. E. Allsopp, A. Gallimore, J. Elvin, M. P. Kieny, A. V. Hill, A. J. McMichael, and H. C. Whittle. 1993. Cytotoxic T cells in HIV2 seropositive Gambians: identification of a virus-specific MHC-restricted peptide epitope. J. Immunol. 151: 3361-3369.
19. Bertoletti, A., F. Cham, S. McAdam, T. Rostron, S. Rowland-Jones, S. Sabally, T. Corrah, K. Ariyoshi, and H. Whittle. 1998. Cytotoxic T cells from human immunodeficiency virus type 2-infected patients frequently cross-react with different human immunodeficiency virus type 1 clades. J. Virol. 72: 2439-2448.
20. Jaye, A., R. Sarge-Njie, M. Schim van der Loeff, J. Todd, A. Alabi, S. Sabally, T. Corrah, and H. Whittle. 2004. No differences in cellular immune responses between asymptomatic HIV type 1- and type 2-infected Gambian patients. J. Infect. Dis. 189: 498-505.
21. + T cell responses to human immunodeficiency viruses type 2 (HIV-2) and type 1 (HIV-1) gag proteins are distinguishable by magnitude and breadth but not cellular phenotype. Eur. J. Immunol. 35: 1445-1453.
22. Sousa, A. E., A. F. Chaves, A. Loureiro, and R. M. Victorino. 2001. Comparison of the frequency of interleukin (IL)-2-, interferon-γ-, and IL-4-producing T cells in 2 diseases, human immunodeficiency virus types 1 and 2, with distinct clinical outcomes. J. Infect. Dis. 184: 552-559.
23. Pinto, L. A., M. J. Covas, and R. M. Victorino. 1993. T-helper cross reactivity to viral recombinant proteins in HIV-2-infected patients. AIDS 7: 1389-1391.
24. Pinto, L. A., M. J. Covas, and R. M. Victorino. 1995. T-helper reactivity to simian immunodeficiency virus gag synthetic peptides in human immunodeficiency virus type 2 infected individuals. J. Med. Virol. 47: 139-144.
25. Zheng, N. N., N. B. Kiviat, P. S. Sow, S. E. Hawes, A. Wilson, H. Diallo-Agne, C. W. Critchlow, G. S. Gottlieb, L. Musey, and M. J. McElrath. 2004. Comparison of human immunodeficiency virus (HIV)-specific T-cell responses in HIV-1- and HIV-2-infected individuals in Senegal. J. Virol. 78: 13934-13942.
26. Hansmann, A., M. F. Schim van der Loeff, S. Kaye, A. A. Awasana, R. Sarge-Njie, D. O'Donovan, K. Ariyoshi, A. Alabi, P. Milligan, and H. C. Whittle. 2005. Baseline plasma viral load and CD4 cell percentage predict survival in HIV-1- and HIV-2-infected women in a community-based cohort in The Gambia. J. Acquir. Immune Defic. Syndr. 38: 335-341.
27. Alabi, A. S., S. Jaffar, K. Ariyoshi, T. Blanchard, M. Schim van der Loeff, A. A. Awasana, T. Corrah, S. Sabally, R. Sarge-Njie, F. Cham-Jallow, et al. 2003. Plasma viral load, CD4 cell percentage, HLA and survival of HIV-1, HIV-2, and dually infected Gambian patients. AIDS 17: 1513-1520.
28. Berry, N., K. Ariyoshi, S. Jaffar, S. Sabally, T. Corrah, R. Tedder, and H. Whittle. 1998. Low peripheral blood viral HIV-2 RNA in individuals with high CD4 percentage differentiates HIV-2 from HIV-1 infection. J. Hum. Virol. 1: 457-468.
29. Ariyoshi, K., M. Schim van der Loeff, N. Berry, S. Jaffar, and H. Whittle. 1999. Plasma HIV viral load in relation to season and to Plasmodium falciparum parasitaemia. AIDS 13: 1145-1146.
30. Cham, F., L. Heyndrickx, W. Janssens, G. Van der Auwera, K. Vereecken, K. De Houwer, S. Coppens, H. Whittle, and G. van der Groen. 2000. Study of HIV type 1 gag/env variability in The Gambia, using a multiplex DNA polymerase chain reaction. AIDS Res. Hum. Retroviruses 16: 1915-1919.
31. Andersson, S., H. Norrgren, F. Dias, G. Biberfeld, and J. Albert. 1999. Molecular characterization of human immunodeficiency virus (HIV)-1 and -2 in individuals from Guinea-bissau with single or dual infections: predominance of a distinct HIV-1 subtype A/G recombinant in West Africa. Virology 262: 312-320.
32. Berry, N., K. Ariyoshi, P. Balfe, R. Tedder, and H. Whittle. 2001. Sequence specificity of the human immunodeficiency virus type 2 (HIV-2) long terminal repeat u3 region in vivo allows subtyping of the principal HIV-2 viral subtypes a and b. AIDS Res. Hum. Retroviruses 17: 263-267.
33. + T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression. Nat. Med. 5: 518-525.
34. + T-cell responses: relationship to viral load in untreated HIV infection. J. Virol. 75: 11983-11991.
35. Addo, M. M., X. G. Yu, A. Rathod, D. Cohen, R. L. Eldridge, D. Strick, M. N. Johnston, C. Corcoran, A. G. Wurcel, C. A. Fitzpatrick, et al. 2003. Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load. J. Virol. 77: 2081-2092.
36. Guyader, M., M. Emerman, P. Sonigo, F. Clavel, L. Montagnier, and M. Alizon. 1987. Genome organization and transactivation of the human immunodeficiency virus type 2. Nature 326: 662-669.
37. + T cells. Blood 101: 2711-2720.
38. + T cells is associated with diminished interleukin-2 (IL-2) production and is recovered by exogenous IL-2. J. Virol. 77: 10900-10909.
39. + T cells endowed with proliferative capacity. J. Exp. Med. 198: 1909-1922.
40. Musey, L. K., J. N. Krieger, J. P. Hughes, T. W. Schacker, L. Corey, and M. J. McElrath. 1999. Early and persistent human immunodeficiency virus type 1 (HIV-1)-specific T helper dysfunction in blood and lymph nodes following acute HIV-1 infection. J. Infect. Dis. 180: 278-284.
41. + T cells. Nature 417: 95-98.
42. + T cells. Nature 434: 1148-1152.
43. + T cells in multiple tissues during acute SIV infection. Nature 434: 1093-1097.
44. + T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J. Exp. Med. 200: 749-759.
45. + T lymphocytes from effector sites in the gastrointestinal tract. J. Exp. Med. 200: 761-770.
46. Harari, A., F. Vallelian, P. R. Meylan, and G. Pantaleo. 2005. Functional heterogeneity of memory CD4 T cell responses in different conditions of antigen exposure and persistence. J. Immunol. 174: 1037-1045.
47. Harari, A., S. Petitpierre, F. Vallelian, and G. Pantaleo. 2004. Skewed representation of functionally distinct populations of virus-specific CD4 T cells in HIV-1-infected subjects with progressive disease: changes after antiretroviral therapy. Blood 103: 966-972.
48. Roederer, M., J. M. Brenchley, M. R. Betts, and S. C. De Rosa. 2004. Flow cytometric analysis of vaccine responses: how many colors are enough? Clin. Immunol. 110: 199-205.
49. Wu, C. Y., J. R. Kirman, M. J. Rotte, D. F. Davey, S. P. Perfetto, E. G. Rhee, B. L. Freidag, B. J. Hill, D. C. Douek, and R. A. Seder. 2002. Distinct lineages of Th1 cells have differential capacities for memory cell generation in vivo. Nat. Immunol. 3: 852-858.
50. + T lymphocytes. Nature 421: 852-856.
51. Sun, J. C., and M. J. Bevan. 2003. Defective CD8 T cell memory following acute infection without CD4 T cell help. Science 300: 339-342.
52. Shedlock, D. J., and H. Shen. 2003. Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science 300: 337-339.
53. + T cells after acute infection. Nat. Immunol. 5: 927-933.
54. + T cells, vary in differentiation phenotype in different persistent virus infections. Nat. Med. 8: 379-385.
55. + T-cell differentiation towards senescence in HIV-1 infection. PLoS Biol. 2: E20.
56. + T cells. J. Exp. Med. 200: 701-712.
57. Bjorling, E., G. Scarlatti, A. von Gegerfelt, J. Albert, G. Biberfeld, F. Chiodi, E. Norrby, and E. M. Fenyo. 1993. Autologous neutralizing antibodies prevail in HIV-2 but not in HIV-1 infection. Virology 193: 528-530.
58. Robert-Guroff, M., K. Aldrich, R. Muldoon, T. L. Stern, G. P. Bansal, T. J. Matthews, P. D. Markham, R. C. Gallo, and G. Franchini. 1992. Cross-neutralization of human immunodeficiency virus type 1 and 2 and simian immunodeficiency virus isolates. J. Virol. 66: 3602-3608.
59. J. Virol. Vol. 176 No. 11